Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Shares Outstanding: 16.01M for March 11, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| March 11, 2024 | 16.01M |
| March 08, 2024 | 16.01M |
| March 07, 2024 | 16.01M |
| December 31, 2023 | 13.02M |
| November 09, 2023 | 13.02M |
| September 30, 2023 | 13.02M |
| August 25, 2023 | 13.02M |
| August 10, 2023 | 13.02M |
| August 09, 2023 | 13.02M |
| July 24, 2023 | 13.02M |
| Date | Value |
|---|---|
| July 23, 2023 | 13.02M |
| July 14, 2023 | 13.02M |
| June 30, 2023 | 11.72M |
| May 09, 2023 | 11.72M |
| March 31, 2023 | 11.72M |
| March 29, 2023 | 11.63M |
| March 28, 2023 | 11.63M |
| March 27, 2023 | 11.63M |
| January 20, 2023 | 11.63M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
11.63M
Minimum
Jan 20 2023
16.01M
Maximum
Mar 07 2024
13.00M
Average
13.02M
Median
Jul 14 2023
Shares Outstanding Benchmarks
| Tenax Therapeutics Inc | 1.958M |
| Syra Health Corp | 6.565M |
| Minerva Neurosciences Inc | 6.993M |
| Adverum Biotechnologies Inc | 20.75M |
| Genprex Inc | 1.910M |